Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Kelly Frye0
Kenneth Graham0
Daniel Dix0
Eric Furfine0
Date of Patent
November 5, 2019
Patent Application Number
16159269
Date Filed
October 12, 2018
Patent Citations Received
...
Patent Primary Examiner
Patent abstract
Ophthalmic formulations of a vascular endothelial growth factor (VEGF)-specific fusion protein antagonist are provided suitable for intravitreal administration to the eye. The ophthalmic formulations include a stable liquid formulation and a lyophilizable formulation. Preferably, the protein antagonist has an amino acid sequence of SEQ ID NO: 4.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.